Aptevo Therapeutics Reports Second Quarter 2017 Financial Results

Published: Aug 10, 2017

SEATTLE, Aug. 10, 2017 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq:APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, today provided a business review and reported its financial results for the second quarter ended June 30, 2017.

ā€œIā€™m extremely proud of our achievements so far in 2017, particularly when you consider our short history as an independent company,ā€ commented Marvin L. White, President and Chief Executive Officer.

Back to news